Chapter
Efficacy of Vaccines and Risk of Myocarditis
40:33 - 44:52 (04:19)
The efficacy of vaccines decreases over time due to the evolution of viruses, making it a policy and behavioral question. Furthermore, a recent study in Nature suggests that the risk of myocarditis is elevated among young men aged 18 to 24 who received the vaccine.
Clips
A reporter from Rebel News confronts Burlough, asking when he knew that the vaccines didn't stop transmission, revealing the fact that it had been kept secret from the public.
40:33 - 42:04 (01:31)
Summary
A reporter from Rebel News confronts Burlough, asking when he knew that the vaccines didn't stop transmission, revealing the fact that it had been kept secret from the public.
ChapterEfficacy of Vaccines and Risk of Myocarditis
EpisodeE113: DOJ tries to break up Google, vaccine questions, Ukraine escalation & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The COVID-19 vaccine efficacy may decrease over time due to the virus evolving, leading to the antibodies produced by the original vaccine becoming less effective.
42:04 - 44:52 (02:48)
Summary
The COVID-19 vaccine efficacy may decrease over time due to the virus evolving, leading to the antibodies produced by the original vaccine becoming less effective. Moreover, a study in Nature suggests that young people, primarily young men aged 18 to 24 years, may have a higher risk of myocarditis or inflammation of the heart tissue after receiving the vaccine.